LSNE in API and Fill-Finish Pact

LSNE Contract Manufacturing has signed a manufacturing supply agreement with Selecta Biosciences, a clinical-stage biopharmaceutical company focused on using its Synthetic Vaccine Particle (SVP) platform to develop biologic therapies for rare diseases. LSNE will provide drug substance manufacturing and fill/finish services.

LSNE Contract Manufacturing is a contract development and manufacturing organization with facilities in Bedford and Manchester, New Hampshire, and specializing in process development and cGMP fill/finish and lyophilization.

Source: LSNE Contract Manufacturing

Leave a Reply

Your email address will not be published. Required fields are marked *